Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 19 de 19
Filtrer
1.
BMC Med Imaging ; 22(1): 84, 2022 05 10.
Article de Anglais | MEDLINE | ID: mdl-35538520

RÉSUMÉ

OBJECTIVE: To investigate whether radiomics based on ultrasound images can predict lymphovascular invasion (LVI) of rectal cancer (RC) before surgery. METHODS: A total of 203 patients with RC were enrolled retrospectively, and they were divided into a training set (143 patients) and a validation set (60 patients). We extracted the radiomic features from the largest gray ultrasound image of the RC lesion. The intraclass correlation coefficient (ICC) was applied to test the repeatability of the radiomic features. The least absolute shrinkage and selection operator (LASSO) was used to reduce the data dimension and select significant features. Logistic regression (LR) analysis was applied to establish the radiomics model. The receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) were used to evaluate the comprehensive performance of the model. RESULTS: Among the 203 patients, 33 (16.7%) were LVI positive and 170 (83.7%) were LVI negative. A total of 5350 (90.1%) radiomic features with ICC values of ≥ 0.75 were reported, which were subsequently subjected to hypothesis testing and LASSO regression dimension reduction analysis. Finally, 15 selected features were used to construct the radiomics model. The area under the curve (AUC) of the training set was 0.849, and the AUC of the validation set was 0.781. The calibration curve indicated that the radiomics model had good calibration, and DCA demonstrated that the model had clinical benefits. CONCLUSION: The proposed endorectal ultrasound-based radiomics model has the potential to predict LVI preoperatively in RC.


Sujet(s)
Tumeurs du rectum , Aire sous la courbe , Humains , Courbe ROC , Tumeurs du rectum/imagerie diagnostique , Tumeurs du rectum/chirurgie , Études rétrospectives , Échographie
2.
Hepatology ; 76(1): 66-77, 2022 07.
Article de Anglais | MEDLINE | ID: mdl-35007334

RÉSUMÉ

BACKGROUND AND AIMS: The study objective was to compare the effectiveness of microwave ablation (MWA) and laparoscopic liver resection (LLR) on solitary 3-5-cm HCC over time. APPROACH AND RESULTS: From 2008 to 2019, 1289 patients from 12 hospitals were enrolled in this retrospective study. Diagnosis of all lesions were based on histopathology. Propensity score matching was used to balance all baseline variables between the two groups in 2008-2019 (n = 335 in each group) and 2014-2019 (n = 257 in each group) cohorts, respectively. For cohort 2008-2019, during a median follow-up of 35.8 months, there were no differences in overall survival (OS) between MWA and LLR (HR: 0.88, 95% CI 0.65-1.19, p = 0.420), and MWA was inferior to LLR regarding disease-free survival (DFS) (HR 1.36, 95% CI 1.05-1.75, p = 0.017). For cohort 2014-2019, there was comparable OS (HR 0.85, 95% CI 0.56-1.30, p = 0.460) and approached statistical significance for DFS (HR 1.33, 95% CI 0.98-1.82, p = 0.071) between MWA and LLR. Subgroup analyses showed comparable OS in 3.1-4.0-cm HCCs (HR 0.88, 95% CI 0.53-1.47, p = 0.630) and 4.1-5.0-cm HCCs (HR 0.77, 95% CI 0.37-1.60, p = 0.483) between two modalities. For both cohorts, MWA shared comparable major complications (both p > 0.05), shorter hospitalization, and lower cost to LLR (all p < 0.001). CONCLUSIONS: MWA might be a first-line alternative to LLR for solitary 3-5-cm HCC in selected patients with technical advances, especially for patients unsuitable for LLR.


Sujet(s)
Carcinome hépatocellulaire , Ablation par cathéter , Laparoscopie , Tumeurs du foie , Carcinome hépatocellulaire/anatomopathologie , Hépatectomie , Humains , Tumeurs du foie/anatomopathologie , Micro-ondes/usage thérapeutique , Score de propension , Études rétrospectives , Résultat thérapeutique
3.
Bioengineered ; 12(1): 4233-4246, 2021 12.
Article de Anglais | MEDLINE | ID: mdl-34304708

RÉSUMÉ

Tumor glycolysis is a major promoter of carcinogenesis and cancer progression. Given its complex mechanisms and interactions, comprehensive analysis is needed to reveal its clinical significance and molecular features. On the basis of a well-established glycolysis gene expression signature, we quantified 8633 patients with different cancer types from the Cancer Genome Atlas (TCGA) and evaluated their prognostic associations. High tumor glycolytic activity correlated with inferior overall survival in the pan-cancer patients (hazard ratio: 1.70, 95% confidence interval: 1.20-2.40, P = 0.003). The prognostic value of glycolysis correlated with the molecular subtypes and was stable regardless of clinical parameters. The prognostic significance of glycolysis was validated using three independent datasets. In addition, genome, transcriptome, and proteome profiles were utilized to characterize the distinctive molecular features associated with glycolysis. Mechanistically, glycolysis fulfilled the fundamental needs of tumor proliferation in multiple ways. Exploration of the relationships between glycolysis and tumor-infiltrating immune cells showed that glycolysis enabled the immune evasion of tumor cells. Mammalian target of rapamycin (mTOR) inhibitors and dopamine receptor antagonists can effectively reverse the glycolytic status of cancers. Overall, our study provides an in-depth molecular understanding of tumor glycolysis and may have practical implications for clinical cancer therapy.


Sujet(s)
Glycolyse/génétique , Tumeurs , Transcriptome/génétique , Biologie informatique , Femelle , Régulation de l'expression des gènes tumoraux/génétique , Humains , Mâle , Adulte d'âge moyen , Tumeurs/diagnostic , Tumeurs/génétique , Tumeurs/immunologie , Tumeurs/mortalité , Pronostic , Échappement de la tumeur à la surveillance immunitaire/génétique
4.
J Ultrasound Med ; 40(6): 1229-1244, 2021 Jun.
Article de Anglais | MEDLINE | ID: mdl-32951217

RÉSUMÉ

OBJECTIVES: To develop radiomic models of B-mode ultrasound (US) signatures for determining the origin of primary tumors in metastatic liver disease. METHODS: A total of 254 patients with a diagnosis of metastatic liver disease were included in this retrospective study. The patients were divided into 3 groups depending on the origin of the primary tumor: group 1 (digestive tract versus non-digestive tract tumors), group 2 (breast cancer versus non-breast cancer), and group 3 (lung cancer versus other malignancies). The patients in each group were allocated to a training or testing set (a ratio of 8:2). The region of interest of liver metastasis was determined through manual differentiation of the tumors, and radiomic signatures were acquired from B-mode US images. Optimal features were selected to develop 3 radiomic models using multiple-dimensionality reduction and classifier screening. The area under the curve (AUC) of the receiver operating characteristic curve was applied to assess each model's performance. RESULTS: A total of 5936 features were extracted, and 40, 6, and 14 optimal features were sequentially identified for the development of radiomic models for groups 1, 2, and 3, respectively, with training set AUC values of 0.938, 0.974, and 0.768 and testing set AUC values of 0.767, 0.768, and 0.750. The differences in age, sex, and number of liver metastatic lesions varied greatly between the 4 primary tumors (P < .050). CONCLUSIONS: B-mode US radiomic models could be effective supplemental means to identify the origin of hepatic metastatic lesions (ie, unknown primary sites).


Sujet(s)
Tumeurs du foie , Aire sous la courbe , Humains , Tumeurs du foie/imagerie diagnostique , Courbe ROC , Études rétrospectives , Échographie
5.
Int J Oncol ; 53(2): 603-619, 2018 Aug.
Article de Anglais | MEDLINE | ID: mdl-29749543

RÉSUMÉ

Thyroid cancer (TC) is the most common endocrine malignancy, accounting for approximately 90% of all malignancies of the endocrine system. Despite the fact that patients with TC tend to have good prognoses, the high incidence rate and lymph node metastases remain unresolved issues. Autophagy is an indispensable process that maintains intracellular homeostasis; however, the role of autophagy in several steps of the initiation and progression of TC has not yet been elucidated. In this study, we first identified several autophagy-related genes (ARGs) that were provoked in the onset of TC. Subsequently, a bioinformatics analysis hinted that these genes were markedly disturbed in several proliferative signaling pathways. Moreover, we demonstrated that the differentially expressed ARGs were closely related to several aggressive clinical manifestations, including an advanced tumor stage and lymph node metastasis. Our study further selected prognostic ARGs and developed a prognostic signature based on three key genes (ATG9B, BID and B1DNAJB1), which displayed a moderate ability to predict the prognosis of TC. On the whole, the findings of this study demonstrate that ARGs disrupt proliferation-related pathways and consequently lead to aggressive clinical manifestations. These findings provide insight into the potential molecular mechanisms of action of ARGs and their clinical significance, and also provide classification information of potential therapeutic significance.


Sujet(s)
Protéines associées à l'autophagie/génétique , Analyse de profil d'expression de gènes/méthodes , Réseaux de régulation génique , Tumeurs de la thyroïde/génétique , Tumeurs de la thyroïde/anatomopathologie , Autophagie , Protéine Bid/génétique , Prolifération cellulaire , Évolution de la maladie , Femelle , Régulation de l'expression des gènes tumoraux , Protéines du choc thermique HSP40/génétique , Humains , Métastase lymphatique , Mâle , Protéines membranaires/génétique , Stadification tumorale , Pronostic , Études prospectives
6.
Oncotarget ; 7(14): 18247-61, 2016 Apr 05.
Article de Anglais | MEDLINE | ID: mdl-26919096

RÉSUMÉ

MiR-206 is low expression in lung cancers and associated with cancer metastasis. However, the roles of miR-206 in epithelial-mesenchymal transition (EMT) and angiogenesis in lung cancer remain unknown. In this study, we find that hepatocyte growth factor (HGF) induces EMT, invasion and migration in A549 and 95D lung cancer cells, and these processes could be markedly inhibited by miR-206 overexpression. Moreover, we demonstrate that miR-206 directly targets c-Met and inhibits its downstream PI3k/Akt/mTOR signaling pathway. In contrast, miR-206 inhibitors promote the expression of c-Met and activate the PI3k/Akt/mTOR signaling, and this effect could be attenuated by the PI3K inhibitor. Moreover, c-Met overexpression assay further confirms the significant inhibitory effect of miR-206 on HGF-induced EMT, cell migration and invasion. Notably, we also find that miR-206 effectively inhibits HGF-induced tube formation and migration of human umbilical vein endothelial cells (HUVECs), and the mechanism is also related to inhibition of PI3k/Akt/mTOR signaling. Finally, we reveal the inhibitory effect of miR-206 on EMT and angiogenesis in xenograft tumor mice model. Taken together, miR-206 inhibits HGF-induced EMT and angiogenesis in lung cancer by suppressing c-Met/PI3k/Akt/mTOR signaling. Therefore, miR-206 might be a potential target for the therapeutic strategy against EMT and angiogenesis of lung cancer.


Sujet(s)
Carcinome pulmonaire non à petites cellules/anatomopathologie , Transition épithélio-mésenchymateuse/génétique , Facteur de croissance des hépatocytes/métabolisme , Tumeurs du poumon/anatomopathologie , microARN/génétique , Néovascularisation pathologique/anatomopathologie , Phosphatidylinositol 3-kinases/métabolisme , Protéines proto-oncogènes c-akt/métabolisme , Protéines proto-oncogènes c-met/métabolisme , Sérine-thréonine kinases TOR/métabolisme , Cellules A549 , Animaux , Lignée cellulaire tumorale , Mouvement cellulaire/physiologie , Cellules endothéliales de la veine ombilicale humaine/métabolisme , Humains , Poumon/vascularisation , Poumon/anatomopathologie , Mâle , Souris , Souris de lignée BALB C , Souris nude , microARN/métabolisme , Invasion tumorale/anatomopathologie , Transplantation tumorale , Inhibiteurs des phosphoinositide-3 kinases , Transduction du signal , Transplantation hétérologue
7.
Mol Biosyst ; 11(8): 2290-302, 2015 Aug.
Article de Anglais | MEDLINE | ID: mdl-26075299

RÉSUMÉ

MiRNAs associated with the metastasis of lung cancer remain largely unexplored. In this study, gene and miRNA expression profiling were performed to analyze the global expression of mRNAs and miRNAs in human high- and low-metastatic lung cancer cell strains. By developing an integrated bioinformatics analysis, six miRNAs (miR-424-3p, miR-450b-5p, miR-335-5p, miR-34a-5p, miR-302b-3p and miR-206) showed higher target gene degrees in the miRNA-gene network and might be potential metastasis-related miRNAs. Using the qRT-PCR method, the six miRNAs were further confirmed to show a significant expression difference between human lung cancer and normal tissue samples. Since miR-206 showed lower expression both in lung cancer tissues and cell lines, it was used as an example for further functional verification. The wound healing assay and transwell invasion assay showed that miR-206 mimics significantly inhibited the cell migration and invasion of the high-metastatic lung cancer 95D cell strain. One of its predicted targets in our miRNA-gene network, MET, was also obviously decreased at the protein level when miR-206 was overexpressed. Instead, miR-206 inhibitors increased MET protein expression, cell migration and invasion of the low-metastatic lung cancer 95C cell strain. Meanwhile, the luciferase assay showed that MET was a direct target of miR-206. Furthermore, MET gene silence showed a similar anti-migration and anti-invasion effect with miR-206 mimics in 95D cells and could partially attenuate the migration- and invasion-promoting effect of miR-206 inhibitors in 95C cells, suggesting that miR-206 targets MET in lung cancer metastasis. Finally, we also demonstrated that miR-206 can significantly inhibit lung cancer proliferation and metastasis in mouse models. In conclusion, our study provided a miRNA-gene regulatory network in lung cancer metastasis and further demonstrated the roles of miR-206 and MET in this process, which enhances the understanding of the regulatory mechanism in lung cancer metastasis.


Sujet(s)
Réseaux de régulation génique , Tumeurs du poumon/génétique , microARN/biosynthèse , Métastase tumorale/génétique , Protéines proto-oncogènes c-met/biosynthèse , Adulte , Sujet âgé , Animaux , Lignée cellulaire tumorale , Mouvement cellulaire/génétique , Prolifération cellulaire/génétique , Femelle , Régulation de l'expression des gènes tumoraux , Humains , Tumeurs du poumon/anatomopathologie , Mâle , Souris , microARN/génétique , Adulte d'âge moyen , Invasion tumorale/génétique , Invasion tumorale/anatomopathologie , Métastase tumorale/anatomopathologie , Protéines proto-oncogènes c-met/génétique , ARN messager/génétique , Tests d'activité antitumorale sur modèle de xénogreffe
8.
Turk Neurosurg ; 24(2): 163-9, 2014.
Article de Anglais | MEDLINE | ID: mdl-24831355

RÉSUMÉ

AIM: To understand the mechanism of the gamma knife treating the trigeminal neuralgia. MATERIAL AND METHODS: Using the MASEP-SRRS type gamma knife treatment system, 140 Chinese patients with trigeminal neuralgia (NT) were treated in our hospital from 2002 to 2010, in which the pain relief rate reached 95% and recurrence rate was 3% only. We investigated the effect of the gamma knife treatment on the trigeminal nerve root in 20 Chinese patients with primary trigeminal neuralgia by the magnetic resonance imager (MRI) observation. RESULTS: 1) The cross-sectional area of trigeminal nerve root became smaller and MRI signals were lower in the treatment side than those in the non-treatment side after the gamma knife treatment of primary trigeminal neuralgia; 2) in the treatment side, the cross-sectional area of the trigeminal nerve root decreased significantly after the gamma knife treatment; 3) there was good correlation between the clinical improvement and the MRI findings; and 4) the straight distance between the trigeminal nerve root and the brainstem did not change after the gamma knife treatment. CONCLUSION: The pain relief induced the gamma knife radiosurgery might be related with the atrophy of the trigeminal nerve root in Chinese patients with primary trigeminal neuralgia.


Sujet(s)
Tumeurs du cerveau/chirurgie , Tronc cérébral/chirurgie , Radiochirurgie , Nerf trijumeau/chirurgie , Névralgie essentielle du trijumeau/chirurgie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Imagerie par résonance magnétique/méthodes , Mâle , Adulte d'âge moyen , Récidive , Résultat thérapeutique
9.
J Nutr Biochem ; 25(2): 177-85, 2014 Feb.
Article de Anglais | MEDLINE | ID: mdl-24445042

RÉSUMÉ

Curcumin, a natural and crystalline compound isolated from the plant Curcuma longa with low toxicity in normal cells, has been shown to protect against carcinogenesis and prevent tumor development. However, little is known about antimetastasis effects and mechanism of curcumin in lung cancer. Rac1 is an important small Rho GTPases family protein and has been widely implicated in cytoskeleton rearrangements and cancer cell migration, invasion and metastasis. In this study, we examined the influence of curcumin on in vitro invasiveness of human lung cancer cells and the expressions of Rac1. The results indicate that curcumin at 10 µM slightly reduced the proliferation of 801D lung cancer cells but showed an obvious inhibitory effect on epidermal growth factor or transforming growth factor ß1-induced lung cancer cell migration and invasion. Meanwhile, we demonstrated that the suppression of invasiveness correlated with inhibition of Rac1/PAK1 signaling pathways and matrix metalloproteinase (MMP) 2 and 9 protein expression by combining curcumin treatment with the methods of Rac1 gene silence and overexpression in lung cancer cells. Laser confocal microscope also showed that Rac1-regulated actin cytoskeleton rearrangement may be involved in anti-invasion effect of curcumin on lung cancer cell. At last, through xenograft experiments, we confirmed the connection between Rac1 and the growth and metastasis inhibitory effect of curcumin in vivo. In summary, these data demonstrated that low-toxic levels of curcumin could efficiently inhibit migration and invasion of lung cancer cells through inhibition of Rac1/PAK1 signaling pathway and MMP-2 and MMP-9 expression, which provided a novel insight into the molecular mechanism of curcumin against lung cancer.


Sujet(s)
Mouvement cellulaire , Curcumine/pharmacologie , Tumeurs du poumon/anatomopathologie , Invasion tumorale , Transduction du signal , Protéine G rac1/métabolisme , Lignée cellulaire tumorale , Humains , Phosphorylation , p21-Activated Kinases/métabolisme
10.
Mol Biosyst ; 9(12): 3080-90, 2013 Dec.
Article de Anglais | MEDLINE | ID: mdl-24077187

RÉSUMÉ

Metastasis is a common feature of lung cancer, involving relationships between genes, proteins and miRNAs. However, lack of early detection and limited options for targeted therapies are weaknesses that cantribute to the dismal statistics observed in lung cancer metastasis. In this paper, gene expression profiling analysis for genes differentially expressed between high- (95D) and low-metastatic lung cancer cell lines (95C) was performed using gene annotation, pathway analysis, literature mining, and the integrated regulatory network as well as motif analysis of miRNA-DEG and TF-DEG. In addition, the expression of EGR-1 (early growth reponse-1) in surgically resected lung squamous carcinomas, adenocarcinomas and normal lung tissue was detected by immunohistochemistry to reveal the relationships between EGR-1 and lung cancer metastasis. A total of 570 different expressed genes (DEGs) were screened, the vast majority of up-regulated DEGs were connected to cell adhesion and focal adhesion. EGR-1 was observed in the center node of the regulatory network, which seems to play a role in the process of cancer metastasis, and further immunohistochemistry detection confirmed this reasoning. Besides EGR-1, several significant module-related DEGs were enriched in the pathway within cancer and focal adhesion according to KEGG pathway enrichment analysis of network modules. The construction of an integrated regulatory network and the functional prediction of EGR-1 provided us with the cytological basis of lung cancer metastasis research and an understanding of the mechanism of metastasis in lung cancer. EGR-1 should be considered as a potential target gene in therapeutic agent for lung cancer metastasis.


Sujet(s)
Facteur de transcription EGR-1/génétique , Facteur de transcription EGR-1/métabolisme , Tumeurs à cellules géantes/génétique , Tumeurs du poumon/génétique , Métastase tumorale/génétique , Lignée cellulaire tumorale , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes tumoraux , Réseaux de régulation génique , Humains , microARN/génétique , Transduction du signal
11.
Asian Pac J Cancer Prev ; 14(2): 639-43, 2013.
Article de Anglais | MEDLINE | ID: mdl-23621211

RÉSUMÉ

AIM: Connexin 43 (Cx43) and E-cadherin are important biomarkers related with cancer. Their expression at protein and mRNA levels was here investigated in 50 primary lung carcinoma tissues and 20 samples of adjacent normal tissue of Chinese patients with non-small cell lung cancer (NSCLC). METHODS: Protein and mRNA expression were evaluated by ABC immunohistochemistry and RT-PCR. RESULTS: (1) The positive expression rates of Cx43 and E-cadherin protein were higher in the adjacent normal tissues than those in the primary lung carcinoma tissues; (2) the positive expression rates of Cx43 and E-cadherin protein decreased with NSCLC progression; (3) the expression of E-cadherin protein was not related with the pathological type of NSCLC; and (4) the relative quantity of the Cx43 or E-cadherin mRNA expression was correlated with the the histological type, clinical stage, cancer cell differentiation and the lymph node metastasis. CONCLUSION: The data suggested that the Cx43 and E-cadherin are reduced with NSCLC progression, and might be important biomarkers for judging the metastasis and prognosis.


Sujet(s)
Cadhérines/biosynthèse , Carcinome pulmonaire non à petites cellules/métabolisme , Connexine 43/biosynthèse , Tumeurs du poumon/métabolisme , Adénocarcinome/génétique , Adénocarcinome/métabolisme , Adénocarcinome/anatomopathologie , Adulte , Sujet âgé , Marqueurs biologiques tumoraux/biosynthèse , Marqueurs biologiques tumoraux/génétique , Cadhérines/génétique , Carcinome pulmonaire non à petites cellules/génétique , Carcinome pulmonaire non à petites cellules/anatomopathologie , Carcinome épidermoïde/génétique , Carcinome épidermoïde/métabolisme , Carcinome épidermoïde/anatomopathologie , Différenciation cellulaire , Chine , Connexine 43/génétique , Évolution de la maladie , Femelle , Expression des gènes , Humains , Poumon/métabolisme , Poumon/anatomopathologie , Tumeurs du poumon/génétique , Tumeurs du poumon/anatomopathologie , Métastase lymphatique/génétique , Métastase lymphatique/anatomopathologie , Mâle , Adulte d'âge moyen , ARN messager/biosynthèse
12.
Neuropeptides ; 47(2): 93-7, 2013 Apr.
Article de Anglais | MEDLINE | ID: mdl-23375440

RÉSUMÉ

Oxytocin (OXT), a nonapeptide hormone of posterior pituitary, reaches the central nervous system from systemic blood circulation with a difficulty because of the blood-brain barrier (BBB). The interest has been expressed in the use of the nasal route for delivery of OXT to the brain directly, exploiting the olfactory pathway. Our previous study has demonstrated that OXT in the central nervous system rather than the blood circulation plays an important role in rat pain modulation. The communication tried to investigate the interaction between the OXT and pain modulation in Chinese patients with headache to understand the OXT effect on human pain modulation. The results showed that (1) intranasal OXT could relieve the human headache in a dose-dependent manner; (2) OXT concentration in both plasma and cerebrospinal fluid (CSF) increased significantly in headache patients in relation with the pain level; and (3) there was a positive relationship between plasma and CSF OXT concentration in headache patients. The data suggested that intranasal OXT, which was delivered to the central nervous system through olfactory region, could treat human headache and OXT might be a potential drug of headache relief by intranasal administration.


Sujet(s)
Céphalée/traitement médicamenteux , Ocytocine/usage thérapeutique , Douleur/traitement médicamenteux , Administration par voie nasale , Adulte , Asiatiques , Relation dose-effet des médicaments , Femelle , Céphalée/physiopathologie , Humains , Mâle , Adulte d'âge moyen , Ocytocine/sang , Ocytocine/liquide cérébrospinal , Douleur/physiopathologie , Mesure de la douleur/effets des médicaments et des substances chimiques , Jeune adulte
13.
Asian Pac J Cancer Prev ; 13(8): 3751-5, 2012.
Article de Anglais | MEDLINE | ID: mdl-23098466

RÉSUMÉ

AIM: Tea polyphenols are known to play roles in critical steps of human lung carcinoma cell metastasis. For understanding the mechanisms whereby they inhibit tumor metastasis, the present study was conducted to investigate their effects on the adhesion of highly metastatic lung carcinoma cell lines (PG cells) to endothelial cells (EC cells) and adhesion molecule expression in vitro. METHODS: The expression of CD44 or CD54 in the PG cells was detected by flow cytometry and adhesion of PG cells to EC cells was assessed by confocal microscopy double fluorescence staining. RESULTS: The results showed that tea polyphenols: (1) inhibited the expression of CD44 and CD54, two important adhesion molecules in the PG cells in a dose-dependent manner; (2) significantly blocked the adhesion of PG cells to EC cells not only in a state of rest but also when active; and (3) influenced CD44 and CD54 expression during the adhesion process of PG cells to EC cells. CONCLUSION: The data indicated that the blocking role of tea polyphenols in the adhesion of PG cells to EC cells is related to CD44 and CD54. The mechanism of tea polyphenol prevention of human lung carcinoma metastasis might be through inhibiting adhesion molecule expression to block cancer cell adhesion.


Sujet(s)
Adhérence cellulaire/effets des médicaments et des substances chimiques , Endothélium vasculaire/effets des médicaments et des substances chimiques , Tumeurs du poumon/secondaire , Polyphénols/pharmacologie , Thé/composition chimique , Technique de Western , Cellules cultivées , Endothélium vasculaire/cytologie , Endothélium vasculaire/métabolisme , Cytométrie en flux , Humains , Antigènes CD44/métabolisme , Molécule-1 d'adhérence intercellulaire/métabolisme , Tumeurs du poumon/traitement médicamenteux , Tumeurs du poumon/métabolisme
14.
Peptides ; 38(1): 100-4, 2012 Nov.
Article de Anglais | MEDLINE | ID: mdl-22963731

RÉSUMÉ

Arginine vasopressin (AVP), a nonapeptide hormone of posterior pituitary, reaches the central nervous system from systemic blood circulation with a difficulty because of the blood-brain barrier (BBB). The interest has been expressed in the use of the nasal route for delivery of AVP to the brain directly, exploiting the olfactory pathway. Our previous study has demonstrated that AVP in the brain rather than the spinal cord and blood circulation plays an important role in rat pain modulation. For understanding the role of AVP on pain modulation in human, the communication tried to investigate the effect of intranasal AVP on human headache. The results showed that (1) AVP concentration in both plasma and cerebrospinal fluid (CSF) increased significantly in headache patients, who related with the headache level; (2) there was a positive relationship between plasma and CSF AVP concentration in headache patients; and (3) intranasal AVP could relieve the human headache in a dose-dependent manner. The data suggested that intranasal AVP, which was delivered to the brain through olfactory region, could treat human headache and AVP might be a potential drug of pain relief by intranasal administration.


Sujet(s)
Arginine vasopressine/administration et posologie , Arginine vasopressine/usage thérapeutique , Céphalée/traitement médicamenteux , Administration par voie nasale , Adulte , Arginine vasopressine/sang , Arginine vasopressine/liquide cérébrospinal , Relation dose-effet des médicaments , Femelle , Humains , Mâle , Adulte d'âge moyen , Résultat thérapeutique , Jeune adulte
15.
Zhonghua Zhong Liu Za Zhi ; 34(6): 436-40, 2012 Jun.
Article de Chinois | MEDLINE | ID: mdl-22967445

RÉSUMÉ

OBJECTIVE: To explore the expression of ezrin protein in human non-small cell lung cancer (NSCLC) tissues and lung cancer cell lines, and the association between the expression of ezrin protein and the expression of E-cadherin and CD44V6 proteins. METHODS: The expression of ezrin protein and mRNA in lung cancer cell lines was detected by RT-PCR and Western blotting. Ezrin, E-cadherin and CD44V6 were detected by immunohistochemical SP staining in tumor tissues from 150 lung cancer cases and in adjacent normal lung tissues from 30 patients. Furthermore, the expression of ezrin in 30 freshly-taken NSCLC tissues was also detected by Western blot. RESULTS: The expression of ezrin protein and mRNA was up-regulated in highly metastatic human lung cancer. The positive rate of ezrin, E-cadherin and CD44V6 expression in the lung cancer was 61.3%, 54.0% and 58.7%, respectively. The up-regulation of ezrin expression was significantly correlated with lymph node metastasis, but not correlated with age, sex, tumor size, histological type, clinical TNM system and pathological grade. Western blot analysis showed that the level of ezrin in the NSCLC tissues was significantly higher than that in the normal tissues (t = 5.013, P < 0.01). Survival analysis showed that the 5-year survival rate of patients with negative ezrin expression was 29.3%, significantly higher than that of patients with positive ezrin expression (15.2%, χ(2) = 4.128, P = 0.042). Multivariate Cox regression analysis showed that ezrin expression (RR = 3.012, P = 0.047) and lymph node metastasis (RR = 4.827, P = 0.035) were significantly independent prognostic factors for patients with lung cancer. Furthermore, a negative correlation was observed between the expressions of ezrin and E-cadherin in lung cancer, and a positive correlation between the expressions of ezrin and CD44V6 in lung cancer. CONCLUSIONS: Ezrin, E-cadherin and CD44V6 play an important role in the regulation of growth and meastasis of lung cancer. Combined detection of ezrin, E-cadherin and CD44V6 expression is helpful in evaluating the metastasis and prognosis of non-small cell lung cancer.


Sujet(s)
Carcinome pulmonaire non à petites cellules/métabolisme , Carcinome pulmonaire non à petites cellules/anatomopathologie , Protéines du cytosquelette/métabolisme , Tumeurs du poumon/métabolisme , Tumeurs du poumon/anatomopathologie , Adulte , Sujet âgé , Antigènes CD , Cadhérines/métabolisme , Lignée cellulaire tumorale , Protéines du cytosquelette/génétique , Femelle , Humains , Antigènes CD44/métabolisme , Métastase lymphatique , Mâle , Adulte d'âge moyen , ARN messager/métabolisme , Taux de survie , Régulation positive
16.
Vet Microbiol ; 159(3-4): 273-81, 2012 Oct 12.
Article de Anglais | MEDLINE | ID: mdl-22771210

RÉSUMÉ

In 2006, highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) caused great economic losses emerged in China and continues to be a threat for the pig industry. B antigenic region (AR) ((37)SHL/FQLIYNL(45)) of GP5 was considered to be a major linear neutralizing AR in PRRSV classical strains. However, peptide-purified antibodies against this AR did not neutralize PRRSV in a recent report. Compared with classical PRRSV, one amino acid mutation (L/F(39)→ I(39)) was found in B AR of HP-PRRSV. To study the ability of B AR of HP-PRRSV to induce neutralizing antibody (NA) in vitro and in vivo, rabbit antisera against B AR with and without the mutation and pig hyperimmune sera with high titer of NAs against HP-PRRSV were prepared. Immunofluorescence assays (IFA) showed that the two rabbit antisera both had reactivity to classical PRRSV CH-1a and HP-PRRSV HuN4 with no observable difference in IFA titer. However, antisera did not have neutralizing activity against classical PRRSV CH-1a and HP-PRRSV HuN4. No correlation was observed between the levels of anti-B AR peptide antibodies and NAs in pig hyperimmune sera that were detected by indirect ELISA and virus neutralization, respectively. B AR peptide-specific serum antibodies had no neutralizing activity and, GST-B fusion protein could not inhibit neutralization of NAs in pig hyperimmune sera. Based on these findings, we conclude that B AR of HP-PRRSV is not a neutralizing AR of HP-PRRSV GP5.


Sujet(s)
Syndrome dysgénésique et respiratoire porcin/immunologie , Virus du syndrome respiratoire et reproducteur porcin/composition chimique , Vaccins antiviraux/immunologie , Animaux , Anticorps neutralisants , Chine , Test ELISA , Peptides/composition chimique , Peptides/immunologie , Lapins , Protéines de fusion recombinantes/composition chimique , Protéines de fusion recombinantes/immunologie , Suidae , Protéines virales/composition chimique , Protéines virales/immunologie
17.
Mol Cell Biochem ; 359(1-2): 389-98, 2012 Jan.
Article de Anglais | MEDLINE | ID: mdl-21874542

RÉSUMÉ

We previously reported that curcumin inhibited lung cancer A549 cells growth and promoted cell apoptosis in vitro. In this study, we further examined the apoptosis-related parameters, including lysosomal damage and cathepsin activation, in A549 cells exposed to curcumin. We found that curcumin caused lysosomal membrane permeabilization (LMP) and cytosolic relocation of cathepsin B (cath B) and cathepsin D (cath D). However, only Z-FA-fmk (a cath B inhibitor) but not pepstatin A (a cath D inhibitor) inhibited curcumin-induced cell apoptosis, mitochondrial membrane potential loss, and cytochrome c release. The antioxidant N-acetylcysteine and glutathione attenuated LMP, suggesting that lysosomal destabilization was dependent on the elevation of reactive oxygen species and which precedes mitochondrial dysfunction. These findings indicated a novel pathway for curcumin regulation of ROS-lysosomal-mitochondrial pathway and provided the key mechanism of regulation of LMP in cell apoptosis, which may be exploited for cancer treatment.


Sujet(s)
Apoptose/effets des médicaments et des substances chimiques , Curcumine/pharmacologie , Membranes intracellulaires/effets des médicaments et des substances chimiques , Tumeurs du poumon/anatomopathologie , Lysosomes/ultrastructure , Antinéoplasiques , Cathepsine B/métabolisme , Cathepsine D/métabolisme , Lignée cellulaire tumorale , Curcumine/usage thérapeutique , Cytochromes c , Humains , Tumeurs du poumon/traitement médicamenteux , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Perméabilité/effets des médicaments et des substances chimiques , Espèces réactives de l'oxygène
18.
Int J Mol Med ; 28(5): 769-76, 2011 Nov.
Article de Anglais | MEDLINE | ID: mdl-21837360

RÉSUMÉ

Rac1, an intracellular signal transducer, regulates a variety of cell functions, including the organization of the cytoskeleton, cell migration, and invasion. Overexpression of Rac1 has been reported in several human cancers. However, the underlying mechanisms are not well understood. In the present study, we evaluated the possibility of Rac1 as an appropriate molecular target for cancer gene therapy. The expression of Rac1 in 150 primary non-small cell lung cancer tissues (NSCLC) and 30 normal paraneoplastic lung tissues was determined by immunohistochemical staining, and the correlation of Rac1 overexpression with clinicopathological factors was evaluated. Overexpression of Rac1 was detected in 94 of 150 lung cancer specimens, the incidence rate being higher than that in normal lung tissue specimens. In addition, overexpression of Rac1 was also associated with poor differentiation, high TNM stage, and lymph node metastasis in NSCLC patients. Moreover, RNAi-mediated suppression of Rac1 expression reduced lamellipodia formation, migration and invasion potential of a lung cancer cell carcinoma cell line, 801D. Down-regulation of Rac1 expression also reduced the expression of Pak1. NSC23766, an inhibitor of Rac1 activity, could also inhibit lung cancer cell migration, invasion and induce rearrangements of the actin cytoskeleton. Furthermore, the suppression of Rac1 expression also sensitized cells to antitumor drugs. These results indicate that the overexpression of Rac1 is tightly associated with an aggressive phenotype of lung cancer cells. Therefore, we proposed that Rac1 could be a potential molecular target of gene therapy by RNAi-targeting in lung cancer cells.


Sujet(s)
Cytosquelette d'actine/métabolisme , Antinéoplasiques/pharmacologie , Mouvement cellulaire/effets des médicaments et des substances chimiques , Tumeurs du poumon/métabolisme , Protéine G rac1/métabolisme , Adulte , Sujet âgé , Technique de Western , Lignée cellulaire tumorale , Mouvement cellulaire/génétique , Prolifération cellulaire/effets des médicaments et des substances chimiques , Femelle , Humains , Immunohistochimie , Techniques in vitro , Tumeurs du poumon/génétique , Mâle , Microscopie confocale , Adulte d'âge moyen , Composés organiques du platine/pharmacologie , Jeune adulte , Protéine G rac1/génétique
19.
Oncol Rep ; 23(5): 1285-92, 2010 May.
Article de Anglais | MEDLINE | ID: mdl-20372842

RÉSUMÉ

Several studies have shown that curcumin can induce apoptosis and inhibit growth in human tumor cell lines. However, the mechanism is not completely understood yet. The present studies were designed to investigate the effects of curcumin on human A549 lung adenocarcinoma cells lines to better understand its effect on apoptosis and apoptosis-related genes in vitro. Apoptosis induction, mitochondria membrane potential, mitochondria structure, and apoptotic associated gene expression were examined by flow cytometric assay, confocal microscopy, Western blotting and electron microscopy. After treatment with curcumin, percentage of apoptotic cells increased dose- and time-dependently, and morphology observation revealed typical apoptotic features. Our data further indicated that the expression of Bax proteins in A549 cells was increased in a dose-dependent manner, whereas the expression of Bcl-2 was significantly decreased, thus the ratio of Bax/Bcl-2 was increased. The apoptotic process was accompanied by the change of mitochondrial function and structure which led to release of the cytochrome c, and activation of caspase-9 and caspase-3. Furthermore, curcumin also induced a dose-dependent cleavage of PARP. Caspases activation during the course of curcumin-induced apoptosis was additionally confirmed by using a broad-spectrum caspases inhibitor, Z-VAD-fmk. As expected, the inhibitor was able to decrease curcumin-induced apoptosis on A549 cells. These results suggested that mitochondria played an important role in the curcumin-induced apoptosis, and mitochondria membrane potential loss initiated apoptosis via the activation of caspases.


Sujet(s)
Adénocarcinome/anatomopathologie , Antinéoplasiques d'origine végétale/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Curcumine/pharmacologie , Tumeurs du poumon/anatomopathologie , Mitochondries/effets des médicaments et des substances chimiques , Adénocarcinome/génétique , Chlorométhyl cétones d'acides aminés/pharmacologie , Apoptose/génétique , Technique de Western , Caspase-3/métabolisme , Caspase-9/métabolisme , Lignée cellulaire tumorale , Forme de la cellule/effets des médicaments et des substances chimiques , Inhibiteurs de la cystéine protéinase/pharmacologie , Cytochromes c/métabolisme , Relation dose-effet des médicaments , Cytométrie en flux , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Humains , Tumeurs du poumon/génétique , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Microscopie confocale , Microscopie électronique à transmission , Mitochondries/anatomopathologie , Poly(ADP-ribose) polymerases/métabolisme , Protéines proto-oncogènes c-bcl-2/métabolisme , Facteurs temps , Protéine Bax/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE